Accéder au contenu
Merck

Choanal atresia associated with prenatal methimazole exposure: three new patients.

American journal of medical genetics. Part A (2004-07-22)
P Barbero, C Ricagni, G Mercado, R Bronberg, M Torrado
RÉSUMÉ

We report three patients with bilateral choanal atresia in children prenatally exposed to methimazole (MMI) in order to define a MMI embryopathy clinical pattern. The combination of choanal atresia and other specific malformations strongly resembles previously reported patients exposed to MMI in utero. At present, propylthiouracil is considered the best treatment in pregnancies. However in Argentina and some other countries MMI is the only antithyroid drug, possibly posing a significant risk to the unborn fetus.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
2-Mercapto-1-methylimidazole, ≥99%
Supelco
Methimazole, analytical standard
USP
Methimazole, United States Pharmacopeia (USP) Reference Standard
Supelco
Methimazole, VETRANAL®, analytical standard
Methimazole, European Pharmacopoeia (EP) Reference Standard